{"id":"NCT01721057","sponsor":"Eli Lilly and Company","briefTitle":"A Study in Moderate to Severe Rheumatoid Arthritis Participants","officialTitle":"A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib (LY3009104) in Patients With Inadequate Response to Conventional Disease-Modifying Antirheumatic Drugs With Moderately to Severely Active Rheumatoid Arthritis","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2012-12","primaryCompletion":"2014-09","completion":"2014-12","firstPosted":"2012-11-02","resultsPosted":"2017-06-12","lastUpdate":"2019-09-18"},"enrollment":684,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Rheumatoid Arthritis"],"interventions":[{"type":"DRUG","name":"Placebo","otherNames":[]},{"type":"DRUG","name":"Baricitinib","otherNames":["LY 3009104","INCB 028050"]},{"type":"DRUG","name":"cDMARD","otherNames":[]}],"arms":[{"label":"Placebo","type":"PLACEBO_COMPARATOR"},{"label":"Baricitinib 2 mg","type":"EXPERIMENTAL"},{"label":"Baricitinib 4 mg","type":"EXPERIMENTAL"}],"summary":"The purpose of this study is to determine whether baricitinib 4 milligram (mg) once daily (QD) is superior to placebo in the treatment of participants with moderately to severely active Rheumatoid Arthritis (RA) who have had inadequate response to or are intolerant to at least 1 conventional disease-modifying antirheumatic drug (cDMARD)(cDMARD-IR \\[inadequate response\\] participants) and who have not received a biologic disease-modifying antirheumatic drug (DMARD).","primaryOutcome":{"measure":"Percentage of Participants Achieving American College of Rheumatology 20% Improvement (ACR20)","timeFrame":"Week 12","effectByArm":[{"arm":"Placebo","deltaMin":39.5,"sd":null},{"arm":"Baricitinib 2 mg","deltaMin":65.9,"sd":null},{"arm":"Baricitinib 4 mg","deltaMin":61.7,"sd":null}],"pValues":[{"comp":"OG000 vs OG002","p":"0.001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":27},"locations":{"siteCount":147,"countries":["United States","Argentina","Australia","Belgium","Canada","Croatia","Czechia","Germany","Hungary","India","Italy","Japan","Mexico","Poland","Portugal","Puerto Rico","Romania","Russia","Slovakia","South Korea","Spain","Taiwan","United Kingdom"]},"refs":{"pmids":["34706874","34526397","34028703","33046136","32414425","30902094","30842122","30219772","30058112","29680881","29463520","28405473","27689735"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":13,"n":228},"commonTop":["Upper respiratory tract infection","Nasopharyngitis","Headache","Urinary tract infection","Diarrhoea"]}}